Dose] koute] Irequency Crdered 23 mg as 1/2 Lab/Cral/ually Is th|s route appropr|ate for pat|ent? ?es /no Dose] koute] Irequency Crdered
Is th|s route appropr|ate for pat|ent? ?es /no n|gh A|ert? es ]No Why? AccldenLal overdosage of oplold analgeslcs has resulLed ln faLallLles 8efore admlnlsLerlng clarlfy all amblguous orders have second pracLlLloner lndependenLly check orlglnal order and dose calculaLlons n|gh A|ert? es ]No Why? C|ass|f|cat|on (1herapeut|c]harmaco|og|c) Cplod analgeslc/Cplold agonlsL C|ass|f|cat|on (1herapeut|c]harmaco|og|c)
Act|on (therapeut|c effect) 8lnds Lo oplaLe recepLors ln Lhe CnS AlLers Lhe percepLlon of and response Lo palnful sLlmull whlle produclng generallzed CnS depresslon 1herapeuLlc LffecL(s) uecrease ln severlLy of paln Suppresslon of wlLhdrawal sympLoms durlng deLoxlflcaLlon and malnLenance from heroln and oLher oplolds Act|on (therapeut|c effect)
Why |s th|s person gett|ng th|s med|cat|on (lndlcaLlon) Severe paln Suppresses wlLhdrawal sympLoms ln oplold deLoxlflcaLlon Why |s th|s person gett|ng th|s med|cat|on (lndlcaLlon)
nome Med|cat|on es ]No If yes dose change? (rev|ous dose t|me) unknown nome Med|cat|on es ]No If yes dose change? (rev|ous dose t|me)
harmacok|net|cs (onset peak durat|on metabo||sm) CnseL 3060 mln eak 90120 mln uuraLlon 412 hr MeLabollsm Llver harmacok|net|cs (onset peak durat|on metabo||sm) 1extbook Dose kange (for ordered route and |nd|cat|on) C (AdulLs and Chlldren 8 30 kg) Analgeslc20 mg q 68 hr Cplold deLoxlflcaLlon1340 mg once dally or amounL needed Lo prevenL wlLhdrawal uose may be decreased q 12 days malnLenance dose ls deLermlned on an lndlvldual basls 1extbook Dose kange (for ordered route and |nd|cat|on)
Contra|nd|cat|ons]Caut|ous use PypersenslLlvlLy known alcohol lnLolerance (some oral soluLlons) ConcurrenL MAC lnhlblLor Lherapy use CauLlously ln SLrucLural hearL dlsease concomlLanL dlureLlc use hypokalemla hypomagnesemla hlsLory of arrhyLhmla/syncope or oLher rlsk facLors for arrhyLhmlas ConcurrenL use of drugs LhaL prolong Lhe C1c lnLerval or are C?3A4 lnhlblLors Pead Lrauma lncreased lnLracranlal pressure Severe renal hepaLlc or pulmonary dlsease PypoLhyroldlsm Adrenal lnsufflclency Alcohollsm undlagnosed abdomlnal paln rosLaLlc hyperplasla or Contra|nd|cat|ons]Caut|ous use
ureLeral sLrlcLure Adverse keact|on Common confuslon sedaLlon dlzzlness hypoLenslon and consLlpaLlon
Severe no sympLoms
1ox|c|ty s|gns]Cverdose Ant|dote? lf an oplold anLagonlsL ls requlred Lo reverse resplraLory depresslon or coma naloxone (narcan) ls Lhe anLldoLe ulluLe Lhe 04mg ampule of naloxone ln 10 mL of 09 naCl and admlnlsLer 03 mL (002 mg) by dlrecL lv push every 2 mln lor chlldren and paLlenLs welghlng 40 kg dlluLe 01 mg of naloxone ln 10 mL of 09 naCl for a concenLraLlon of 10 mcg/mL and admlnlsLer 03 mcg/kg every 2 mln 1lLraLe dose Lo avold wlLhdrawal selzures and severe paln Adverse keact|on Common
Severe
1ox|c|ty s|gns]Cverdose Ant|dote?
Adm|n|strat|on arameters ora|]entera| (empty stomach w|th food) arentera| (compat|b|||ty d||ut|on requ|red and rate) Lxplaln LherapeuLlc value of medlcaLlon prlor Lo admlnlsLraLlon Lo enhance Lhe analgeslc effecL 8egularly admlnlsLered doses may be more effecLlve Lhan prn admlnlsLraLlon Analgeslc ls more effecLlve lf admlnlsLered before paln becomes severe lor paLlenLs ln chronlc severe paln Lhe oral soluLlon conLalnlng 3 or 10 mg/3 mL ls recommended on a flxed dose schedule CoadmlnlsLraLlon wlLh nonoplold analgeslcs may have addlLlve analgeslc effecLs and may permlL lower doses MedlcaLlon should be dlsconLlnued gradually afLer long Lerm use Lo prevenL wlLhdrawal sympLoms ulskeLLes (dlsperslble LableLs) are Lo be dlssolved and used for deLoxlflcaLlon and malnLenance LreaLmenL only - C uoses may be admlnlsLered wlLh food or mllk Lo mlnlmlze Cl lrrlLaLlon ulluLe each dose of 10 mg/mL oral concenLraLe wlLh aL leasL 30 mL of waLer or oLher llquld prlor Lo admlnlsLraLlon lnsLrucL paLlenL on how and when Lo ask for and Lake paln medlcaLlon - lnsLrucL paLlenL Lo Lake meLhadone exacLly as dlrecLed lf dose ls less effecLlve afLer a few weeks do noL lncrease dose wlLhouL consulLlng healLh care professlonal - May cause drowslness or dlzzlness Advlse paLlenL Lo call for asslsLance when ambulaLlng or smoklng and Lo avold drlvlng or oLher acLlvlLles requlrlng alerLness unLll response Adm|n|strat|on arameters ora|]entera| (empty stomach w|th food) arentera| (compat|b|||ty d||ut|on requ|red and rate)
Lo medlcaLlon ls known - lnform paLlenL of Lhe poLenLlal for arrhyLhmlas and emphaslze Lhe lmporLance of regular LCCs - CauLlon paLlenL noLlfy healLh care professlonal lf slgns of overdose (dlfflculL or shallow breaLhlng exLreme Llredness or sleeplness blurred vlslon lnablllLy Lo Lhlnk Lalk or walk normally and feellngs of falnLness dlzzlness or confuslon) occur MeLhadone has a prolonged acLlon causlng lncreased rlsk of overdose - Advlse paLlenL Lo change poslLlons slowly Lo mlnlmlze orLhosLaLlc hypoLenslon - CauLlon paLlenL Lo avold concurrenL use of alcohol or oLher CnS depressanLs wlLh Lhls medlcaLlon - Lncourage paLlenL Lo Lurn cough and breaLhe deeply every 2 hr Lo prevenL aLelecLasls Assessment needed (pre dur|ng and post) aln - Assess Lype locaLlon and lnLenslLy of paln prlor Lo and 12 hr (peak) followlng admlnlsLraLlon When LlLraLlng oplold doses lncreases of 2330 should be admlnlsLered unLll Lhere ls elLher a 30 reducLlon ln Lhe paLlenLs paln raLlng on a numerlc or vlsual analogue scale or Lhe paLlenL reporLs saLlsfacLory paln rellef A repeaL dose can be safely admlnlsLered aL Lhe Llme of Lhe peak lf prevlous dose ls lneffecLlve and slde effecLs are mlnlmal CumulaLlve effecLs of Lhls medlcaLlon may requlre perlodlc dose ad[usLmenLs uoses of meLhadone for paLlenLs on meLhadone malnLenance only prevenL wlLhdrawal sympLoms no analgesla ls provlded AddlLlonal oplold doses are requlred for LreaLmenL of paln - An equlanalgeslc charL (see Lqulanalgeslc uoslng Culdellnes) should be used when changlng rouLes or when changlng from one oplold Lo anoLher - Assess blood pressure pulse and resplraLlons before and perlodlcally durlng admlnlsLraLlon lf resplraLory raLe ls 10/mln assess level of sedaLlon uose may need Lo be decreased by 2330 lnlLlal drowslness wlll dlmlnlsh wlLh conLlnued use - Assess bowel funcLlon rouLlnely revenLlon of consLlpaLlon should be lnsLlLuLed wlLh lncreased lnLake of flulds and bulk and wlLh laxaLlves Lo mlnlmlze consLlpaLlng effecLs SLlmulanL laxaLlves should be admlnlsLered rouLlnely lf oplold use exceeds 23 days unless conLralndlcaLed - rolonged use may lead Lo physlcal and psychologlcal dependence and Lolerance 1hls should noL prevenL paLlenL Assessment needed (pre dur|ng and post)
from recelvlng adequaLe analgesla MosL paLlenLs who recelve meLhadone for paln do noL develop psychologlcal dependence rogresslvely hlgher doses may be requlred Lo relleve paln wlLh longLerm Lherapy - Assess for hlsLory of sLrucLural hearL dlsease arrhyLhmla and syncope CbLaln a preLreaLmenL LCC Lo measure C1c lnLerval and followup LCC wlLhln 30 days and annually AddlLlonal LCCs recommended lf dose 100 mg/day or lf paLlenLs have unexplalned syncope or selzures lf C1c lnLerval ls 430 ms buL 300 ms dlscuss poLenLlal rlsks and beneflLs wlLh paLlenLs and monlLor more frequenLly lf Lhe C1c lnLerval 300 ms conslder dlsconLlnulng or reduclng dose ellmlnaLlng conLrlbuLlng facLors (drugs LhaL promoLe hypokalemla) or uslng an alLernaLlve Lherapy Cplold ueLoxlflcaLlon - Assess paLlenL for slgns of oplold wlLhdrawal (lrrlLablllLy runny nose and eyes abdomlnal cramps body aches sweaLlng loss of appeLlLe shlverlng unusually large puplls Lrouble sleeplng weakness yawnlng) MeLhadone malnLenance ls underLaken only by federally approved LreaLmenL cenLers 1hls does noL preclude malnLenance for addlcLs hosplLallzed for oLher condlLlons and who requlre Lemporary malnLenance durlng Lhelr care Lab 1esL ConslderaLlons - May plasma amylase and llpase levels keference(s) uavls urug Culde 12 Lh LdlLlon pp831834 keference(s)
Medicotion worksheet lo//2011 Gener|c Name]8rand Name
Gener|c Name]8rand Name
Dose] koute] Irequency Crdered
Is th|s route appropr|ate for pat|ent? ?es /no Dose] koute] Irequency Crdered
Is th|s route appropr|ate for pat|ent? ?es /no n|gh A|ert? es ]No Why? n|gh A|ert? es ]No Why? C|ass|f|cat|on (1herapeut|c]harmaco|og|c)
C|ass|f|cat|on (1herapeut|c]harmaco|og|c)
Act|on (therapeut|c effect)
Act|on (therapeut|c effect)
Why |s th|s person gett|ng th|s med|cat|on (lndlcaLlon)
Why |s th|s person gett|ng th|s med|cat|on (lndlcaLlon)
nome Med|cat|on es ]No If yes dose change? (rev|ous dose t|me)
nome Med|cat|on es ]No If yes dose change? (rev|ous dose t|me)